Rimegepant Carbonylimidazolide is a process intermediate
associated with the Rimegepant route; Rimegepant is an oral CGRP receptor
antagonist. It is offered for research and process-development purposes only,
subject to patent/licensing review, and no availability is implied. ApiSyn's
custom synthesis capability covers multi-step heterocyclic and chiral
intermediates of this type.
| Chemical Name | 1-(1-(1H-Imidazole-1-carbonyl)piperidin-4-yl)-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one |
| Molecular Formula | C15H16N6O2 |
| Molecular Weight | 312.3 |
| CAS Number | 1373116-06-3 |